Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epitope specificity of neutralizing antibodies against IFN-beta.
Gneiss C, Reindl M, Berger T, Lutterotti A, Ehling R, Egg R, Deisenhammer F. Gneiss C, et al. Among authors: ehling r. J Interferon Cytokine Res. 2004 May;24(5):283-90. doi: 10.1089/107999004323065066. J Interferon Cytokine Res. 2004. PMID: 15153311
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
Khalil M, Reindl M, Lutterotti A, Kuenz B, Ehling R, Gneiss C, Lackner P, Deisenhammer F, Berger T. Khalil M, et al. Among authors: ehling r. J Neuroimmunol. 2006 May;174(1-2):147-56. doi: 10.1016/j.jneuroim.2006.01.012. Epub 2006 Mar 6. J Neuroimmunol. 2006. PMID: 16516980 Clinical Trial.
Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Lutterotti A, Kuenz B, Gredler V, Khalil M, Ehling R, Gneiss C, Egg R, Deisenhammer F, Berger T, Reindl M. Lutterotti A, et al. Among authors: ehling r. J Neuroimmunol. 2006 Dec;181(1-2):145-9. doi: 10.1016/j.jneuroim.2006.09.002. Epub 2006 Oct 13. J Neuroimmunol. 2006. PMID: 17046070
76 results